Main Menu

Dr Paul Huang

Group Leader

The alt text
Dr Paul Huang uses systems biology and molecular pathology to study drug resistance in sarcomas and lung cancer. He trained at Imperial College London and Massachusetts Institute of Technology, and was awarded a Sir Henry Wellcome Fellowship in 2009 and a Cancer Research UK Career Establishment Award in 2015. Group: Molecular and Systems Oncology ORCID 0000-0003-3972-5087


Dr Paul Huang is Leader of the Molecular and Systems Oncology Group in the Division of Molecular Pathology at the Institute of Cancer Research, London.

He is a tenured Faculty member and Reader in Molecular & Translational Oncology within the Division of Molecular Pathology and holds a Cancer Research UK Career Establishment Award.

See all news stories on our website that feature the work of Dr Huang and colleagues.

Read news

He received his PhD in Biological Engineering from Massachusetts Institute of Technology. His laboratory focuses on understanding aberrant signalling networks and drug resistance in sarcomas and lung cancer, with the goal of developing biomarkers and new therapies for these diseases.

Dr Huang is the Deputy Director of the Joint Royal Marsden-ICR Sarcoma Research Centre, one of the largest sarcoma research centres in Europe.

He serves as Vice Chair of the Pathology & Translational Research Committee of the EORTC Soft Tissue and Bone Sarcoma Group and as a member of several panels including the NCRI Sarcoma Clinical Studies Group, the NCRI Cellular Molecular Pathology (CM-Path) Clinical Trial Pathology Advisory Group (CT-PAG), Sarcoma Genomics England GeCIP Steering Group and Research Advisory Committee of Sarcoma UK.

He was elected a Fellow of the Royal Society of Biology in 2020.

Dr Huang is a member of the Cancer Research UK Convergence Science Centre, which brings together leading researchers in engineering, physical sciences, life sciences and medicine to develop innovative ways to address challenges in cancer.

Convergence Science Centre